+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Biochemical and biophysical investigations of the interaction between human glucokinase and pro-apoptotic BAD



Biochemical and biophysical investigations of the interaction between human glucokinase and pro-apoptotic BAD



Plos one 12(2): E0171587



The glycolytic enzyme glucokinase (GCK) and the pro-apoptotic protein BAD reportedly reside within a five-membered complex that localizes to the mitochondria of mammalian hepatocytes and pancreatic β-cells. Photochemical crosslinking studies using a synthetic analog of BAD's BH3 domain and in vitro transcription/translation experiments support a direct interaction between BAD and GCK. To investigate the biochemical and biophysical consequences of the BAD:GCK interaction, we developed a method for the production of recombinant human BAD. Consistent with published reports, recombinant BAD displays high affinity for Bcl-xL (KD = 7 nM), and phosphorylation of BAD at S118, within the BH3 domain, abolishes this interaction. Unexpectedly, we do not detect association of recombinant, full-length BAD with recombinant human pancreatic GCK over a range of protein concentrations using various biochemical methods including size-exclusion chromatography, chemical cross-linking, analytical ultracentrifugation, and isothermal titration calorimetry. Furthermore, fluorescence polarization assays and isothermal titration calorimetry detect no direct interaction between GCK and BAD BH3 peptides. Kinetic characterization of GCK in the presence of high concentrations of recombinant BAD show modest (<15%) increases in GCK activity, observable only at glucose concentrations well below the K0.5 value. GCK activity is unaffected by BAD BH3 peptides. These results raise questions as to the mechanism of action of stapled peptide analogs modeled after the BAD BH3 domain, which reportedly enhance the Vmax value of GCK and stimulate insulin release in BAD-deficient islets. Based on our results, we postulate that the BAD:GCK interaction, and any resultant regulatory effect(s) upon GCK activity, requires the participation of additional members of the mitochondrial complex.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059444550

Download citation: RISBibTeXText

PMID: 28182770


Related references

Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Progress in Biophysics and Molecular Biology 47(1): 31, 1986

Shedding Light on the Interaction of Human Anti-Apoptotic Bcl-2 Protein with Ligands through Biophysical and in Silico Studies. International Journal of Molecular Sciences 20(4):, 2019

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease. Plos one 9(2): E89335, 2014

An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism. Journal of Biological Chemistry 281(49): 37668-37674, 2006

A patent review of glucokinase activators and disruptors of the glucokinase--glucokinase regulatory protein interaction: 2011-2014. Expert Opinion on Therapeutic Patents 24(8): 875-891, 2015

Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors. Journal of Biological Chemistry 283(46): 31333-31340, 2008

Understanding the fate of human serum albumin upon interaction with edifenphos: Biophysical and biochemical approaches. Pesticide Biochemistry and Physiology 145: 46-55, 2018

Fructose-human serum albumin interaction undergoes numerous biophysical and biochemical changes before forming AGEs and aggregates. International Journal of Biological Macromolecules 109: 896-906, 2018

DNA binding and apoptotic induction ability of harmalol in HepG2: Biophysical and biochemical approaches. Chemico-Biological Interactions 258: 142-152, 2016

Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations. Journal of Biological Chemistry 281(52): 40201-7, 2006

Cloning and biochemical characterisation of an Aspergillus niger glucokinase. Evidence for the presence of separate glucokinase and hexokinase enzymes. European Journal of Biochemistry 240(3): 518-525, 1996

Biophysical and biochemical investigations of dsRNA-activated kinase PKR. Methods in Enzymology 430: 373-396, 2007

Biophysical and biochemical investigations of RNA catalysis in the hammerhead ribozyme. Quarterly Reviews of Biophysics 32(3): 241-284, 1999

Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 4. Exploration of a novel binding pocket. Journal of Medicinal Chemistry 57(14): 5949-5964, 2014

Elucidation of the molecular interaction between glucokinase and glucokinase regulatory protein. Diabetologia 44(Suppl. 1): A173, 2001